Updated on 03/18/2022 09:20 am The American pharmaceutical company Moderna asked the Food and Drug Administration (FDA), the regulatory body of the United States, to authorize the administration for those over 18 years of age of a second booster dose of its vaccine against COVID-19 . Moderna’s request is broader than the one made on […]
Tag: Modern
Modern test to combine its anti-COVID vaccine and a specific one against omicron
Updated on 03/10/2022 10:24 am The American pharmaceutical company Moderna announced this Thursday that it has started clinical trials with a booster vaccine against COVID-19 that combines its original formula with a specific one in response to the omicron variant. In a statement, the company said it plans to involve some 375 people who had […]
Pharmaceutical Adium agrees with Moderna to distribute vaccines in America
The pharmaceutical company Adium Pharma, based in Montevideo (Uruguay) and with four production plants in the region, has agreed with Moderna to collaborate in the distribution and marketing of the Spikevax vaccine against COVID-19 in Latin America. “As part of the agreement reached, Adium will collaborate with Moderna in the management of supply contracts already […]
European Medicines Agency explains that the fourth dose in immunocompromised patients is their “first booster”
Updated on 02/03/2022 09:55 am The European Medicines Agency (EMA) has urged giving a fourth dose of Pfizer or Moderna to people with severely weakened immune systems, explaining that it is considered a “first reinforcement”. The head of Vaccination Strategy, Marco Cavaleryexplained that for people with a severely compromised immune system who have already received […]
US fully approves Moderna’s COVID-19 vaccine in adults
Updated on 01/31/2022 02:36 pm The United States Food and Drug Administration (FDA) on Monday gave full approval to Moderna Inc’s COVID-19 vaccine for people 18 years and older, making it the second fully approved injection against coronavirus. Moderna’s vaccine has been authorized for emergency use in the United States since December 2020 and will […]
Moderna would have specific vaccine data for omicron in March
Updated on 01/17/2022 11:51 am Moderna Inc.’s vaccine candidate against the omicron variant of the coronavirus will enter clinical development in the coming weeks, and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said. “The vaccine is running out and should be in the next few weeks. […]
To face omicron, a booster dose of Pfizer or Moderna is required, according to study
:quality(75)/cdn.jwplayer.com/v2/media/l4iFkiC9/poster.jpg)
Updated on 01/07/2022 12:29 pm A study conducted by researchers at the Ragon Institute at Massachusetts General Hospital (United States) has confirmed that a booster dose of the COVID-19 vaccine from Moderna or Pfizer is needed to provide immunity against the omicron variant of SARS-CoV- two. The research results have been published in the journal […]
Moderna will work since January on an adaptation of its vaccine for omicron
Updated on 12/21/2021 08:15 am The Moderna laboratory will begin in January to work on an adaptation of its vaccine to the omicron variant, although if the results are positive, it will be necessary to wait several months for it to be available. The vice president of Moderna, Dan Staner, explained this Tuesday in an […]
Moderna Announces Booster Dose Increases Omicron Protection
:quality(75)/cdn.jwplayer.com/v2/media/fWp73Qkr/poster.jpg)
Updated on 12/20/2021 07:31 am The American pharmaceutical company Moderna has assured today that a booster dose of its vaccine against COVID-19 increases protection against the omicron variant. The multinational has released today the preliminary data of the studies they have carried out on the booster doses and the strategy they plan to implement to […]
Moderna Delays Vaccine Patent Due to Dispute with US Government
Updated on 12/20/2021 02:52 am Moderna Inc. said he delayed the issuance of his patent vaccine COVID with the intention of allowing negotiations with its partners in the Government of U.S on who should be listed as inventors. For its part, the US government is opposed to Moderna listing only scientists from the company, and […]